Expression of CYP1A1 and CYP1B1 in human endothelial cells: Regulation by fluid shear stress

Cardiovascular Research

Volumn 81, Issue 4, 2009, Pages 669-677

  Conway, Daniel E ^a   Sakurai, Yumiko ^a   Weiss, Daiana ^b   Vega, J David ^b   Taylor, W Robert ^a,b   Jo, Hanjoong ^a,b   Eskin, Suzanne G ^a   Marcus, Craig B ^c   McIntire, Larry V ^a  

^a Wallace H Coulter Department of Biomedical Engineering   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OREGON STATE UNIVERSITY   (United States)

Author keywords

Aryl hydrocarbon receptor; CYP1A1; CYP1B1; Shear stress; Vascular endothelial cell

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEAR STRESS;

ANIMALS; AORTA; ARYL HYDROCARBON HYDROXYLASES; ATHEROSCLEROSIS; CELLS, CULTURED; CORONARY VESSELS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MICE; MICE, INBRED C57BL; PULSATILE FLOW; RECEPTORS, ARYL HYDROCARBON; REGIONAL BLOOD FLOW; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; STRESS, MECHANICAL; THROMBOSPONDIN 1; TIME FACTORS;

EID: 60149095115     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn360     Document Type: Article

References (55)

1. Wootton DM, Ku DN. Fluid mechanics of vascular systems, diseases, and thrombosis. Annu Rev Biomed Eng 1999;1:299-329.
2. Chien S. Effects of disturbed flow on endothelial cells. Ann Biomed Eng 2008;36:554-562.
3. Davies PF. Endothelial transcriptome profiles in vivo in complex arterial flow fields. Ann Biomed Eng 2008;36:563-570.
4. Michaelis UR, Fleming I. From endothelium-derived hyperpolarizing factor (EDHF) to angiogenesis: epoxyeicosatrienoic acids (EETs) and cell signaling. Pharmacol Ther 2006;111:584-595.
5. Barouki R, Morel Y. Repression of cytochrome P450 1A1 gene expression by oxidative stress: mechanisms and biological implications. Biochem Pharmacol 2001;61:511-516.
6. Murray GI, Melvin WT, Greenlee WF, Burke MD. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu Rev Pharmacol Toxicol 2001;41:297-316.
7. Denison MS, Nagy SR. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Ann Rev Pharmacol Toxicol 2003;43:309-334.
8. Dabir P, Marinic TE, Krukovets I, Stenina OI. Aryl hydrocarbon receptor is activated by glucose and regulates the thrombospondin-1 gene promoter in endothelial cells. Circ Res 2008;102:1558-1565.
9. Chiaro CR, Patel RD, Marcus CB, Perdew GH. Evidence for an aryl hydrocarbon receptor-mediated cytochrome p450 autoregulatory pathway. Mol Pharmacol 2007;72:1369-1379.
10. Choudhary D, Jansson I, Stoilov I, Sarfarazi M, Schenkman JB. Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1. Drug Metab Dispos 2004;32:840-847.
11. Chambers D, Wilson L, Maden M, Lumsden A. RALDH-independent generation of retinoic acid during vertebrate embryogenesis by CYP1B1. Development 2007;134:1369-1383.
12. Vincent AL, Billingsley G, Buys Y, Levin AV, Priston M, Trope G et al. Digenic inheritance of early-onset glaucoma: CYP1B1, a potential modifier gene. Am J Hum Genet 2002;70:448-460.
13. Vasiliou V, Gonzalez FJ. Role of CYP1B1 in glaucoma. Annu Rev Pharmacol Toxicol 2007;48:333-358.
14. Libby RT, Smith RS, Savinova OV, Zabaleta A, Martin JE, Gonzalez FJ et al. Modification of ocular defects in mouse developmental glaucoma models by tyrosinase. Science 2003;299:1578-1581.
15. Fledderus JO, van Thienen JV, Boon RA, Dekker RJ, Rohlena J, Volger OL et al. Prolonged shear stress and KLF2 suppress constitutive pro-inflammatory transcription through inhibition of ATF2. Blood 2007;109:4249-4257.
16. McCormick SM, Eskin SG, McIntire LV, Teng CL, Lu CM, Russell CG et al. DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc Natl Acad Sci USA 2001;98:8955-8960.
17. Dai G, Kaazempur-Mofrad MR, Natarajan S, Zhang Y, Vaughn S, Blackman BR et al. Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature. Proc Natl Acad Sci USA 2004;101:14871-14876.
18. Ohura N, Yamamoto K, Ichioka S, Sokabe T, Nakatsuka H, Baba A et al. Global analysis of shear stress-responsive genes in vascular endothelial cells. J Atheroscler Thromb 2003;10:304-313.
19. Garcia-Cardena G, Comander J, Anderson KR, Blackman BR, Gimbrone MA Jr. Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc Natl Acad Sci USA 2001;98:4478-4485.
20. Dekker RJ, van Soest S, Fontijn RD, Salamanca S, de Groot PG, VanBavel E et al. Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2). Blood 2002;100:1689-1698.
21. Parmar KM, Larman HB, Dai G, Zhang Y, Wang ET, Moorthy SN et al. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest 2006;116:49-58.
22. Han Z, Miwa Y, Obikane H, Mitsumata M, Takahashi-Yanaga F, Morimoto S et al. Aryl hydrocarbon receptor mediates laminar fluid shear stress-induced CYP1A1 activation and cell cycle arrest in vascular endothelial cells. Cardiovasc Res 2008;77:809-818.
23. Yee A, Bosworth KA, Conway DE, Eskin SG, McIntire LV. Gene expression of endothelial cells under pulsatile non-reversing vs. steady shear stress; comparison of nitric oxide production. Ann Biomed Eng 2008;36:571-579.
24. Frangos JA, McIntire LV, Eskin SG. Shear stress induced stimulation of mammalian cell metabolism. Biotech Bioeng 1987;32:1053-1060.
25. Perktold K, Rappitsch G. Computer simulation of local blood flow and vessel mechanics in a compliant carotid artery bifurcation model. J Biomech 1995;28:845-856.
26. Vidal JD, Vandevoort CA, Marcus CB, Lazarewicz NR, Conley AJ. 2,3,7,8-tetrachlorodibenzo-p-dioxin induces CYP1B1 expression in human luteinized granulosa cells. Arch Biochem Biophys 2005;439:53-60.
27. Cali JJ, Ma D, Sobol M, Simpson DJ, Frackman S, Good TD et al. Luminogenic cytochrome P450 assays. Expert Opin Drug Metab Toxicol 2006;2:629-645.
28. Pollenz RS, Sattler CA, Poland A. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. Mol Pharmacol 1994;45:428-438.
29. Soucek P, Martin MV, Ueng YF, Guengerich FP. Identification of a common cytochrome P450 epitope near the conserved heme-binding peptide with antibodies raised against recombinant cytochrome P450 family 2 proteins. Biochemistry 1995;34:16013-16021.
30. Suo J, Ferrara DE, Sorescu D, Guldberg RE, Taylor WR, Giddens DP. Hemodynamic shear stresses in mouse aortas: implications for atherogenesis. Arterioscler Thromb Vasc Biol 2007;27:346-351.
31. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002;105:1429-1435.
32. Kao S-H, McIntire LV, Rheology. In: Loscalzo J, Schafer AIeds. Thrombosis and Hemorrhage. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2003. p294-314.
33. Kim S, Ko H, Park JE, Jung S, Lee SK, Chun YJ. Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors. J Med Chem 2002;45:160-164.
34. Shimada T, Yamazaki H, Foroozesh M, Hopkins NE, Alworth WL, Guengerich FP. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1. Chem Res Toxicol 1998;11:1048-1056.
35. Song J, Clagett-Dame M, Peterson RE, Hahn ME, Westler WM, Sicinski RR et al. A ligand for the aryl hydrocarbon receptor isolated from lung. Proc Natl Acad Sci USA 2002;99:14694-14699.
36. Eskin SG, Turner NA, McIntire LV. Endothelial cell cytochrome P450 1A1 and 1B1: up-regulation by shear stress. Endothelium 2004;11:1-10.
37. McMillan BJ, Bradfield CA. The aryl hydrocarbon receptor is activated by modified low-density lipoprotein. Proc Natl Acad Sci USA 2007;104:1412-1417.
38. Guo J, Sartor M, Karyala S, Medvedovic M, Kann S, Puga A et al. Expression of genes in the TGF-beta signaling pathway is significantly deregulated in smooth muscle cells from aorta of aryl hydrocarbon receptor knockout mice. Toxicol Appl Pharmacol 2004;194:79-89.
39. Isenberg JS, Ridnour LA, Perruccio EM, Espey MG, Wink DA, Roberts DD. Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner. Proc Natl Acad Sci USA 2005;102:13141- 13146.
40. Rifkind AB. CYP1A in TCDD toxicity and in physiology-with particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates. Drug Metab Rev 2006;38:291-335.
41. Farin FM, Pohlman TH, Omiecinski CJ. Expression of cytochrome P450s and microsomal epoxide hydrolase in primary cultures of human umbilical vein endothelial cells. Toxicol Appl Pharmacol 1994;124:1-9.
42. Zhao W, Parrish AR, Ramos KS. Constitutive and inducible expression of cytochrome P450IA1 and P450IB1 in human vascular endothelial and smooth muscle cells. In Vitro Cell Dev Biol Anim 1998;34:671-673.
43. Thum T, Haverich A, Borlak J. Cellular dedifferentiation of endothelium is linked to activation and silencing of certain nuclear transcription factors: implications for endothelial dysfunction and vascular biology. FASEB J 2000;14:740-751.
44. Choudhary D, Jansson I, Rezaul K, Han DK, Sarfarazi M, Schenkman JB. Cyp1b1 protein in the mouse eye during development: an immunohistochemical study. Drug Metab Dispos 2007;35:987-994.
45. Tang Y, Scheef EA, Wang S, Sorenson CM, Marcus CB, Jefcoate CR, Sheibani N. CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression. Blood, Epub ahead of print November 12, 2008; doi:10.1182/blood-2008-03- 145219.
46. Doshi M, Marcus C, Bejjani BA, Edward DP. Immunolocalization of CYP1B1 in normal, human, fetal and adult eyes. Exp Eye Res 2006;82:24-32.
47. Dubey RK, Gillespie DG, Zacharia LC, Barchiesi F, Imthurn B, Jackson EK. CYP450- and COMT-derived estradiol metabolites inhibit activity of human coronary artery SMCs. Hypertension 2003;41:807-813.
48. Kerzee JK, Ramos KS. Constitutive and inducible expression of Cyp1a1 and Cyp1b1 in vascular smooth muscle cells: role of the Ahr bHLH/PAS transcription factor. Circ Res 2001;89:573-582.
49. Zeldin DC. Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 2001;276:36059-36062.
50. Schwarz D, Kisselev P, Ericksen SS, Szklarz GD, Chernogolov A, Honeck H et al. Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid. Biochem Pharmacol 2004;67:1445-1457.
51. Huang A, Sun D, Jacobson A, Carroll MA, Falck JR, Kaley G. Epoxyeicosatrienoic acids are released to mediate shear stress-dependent hyperpolarization of arteriolar smooth muscle. Circ Res 2005;96:376-383.
52. Liu Y, Zhang Y, Schmelzer K, Lee TS, Fang X, Zhu Y et al. The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase. Proc Natl Acad Sci USA 2005;102:16747-16752.
53. Guengerich FP. Cytochrome p450 and chemical toxicology. Chem Res Toxicol 2008;21:70-83.
54. Zhu M, Fu Y, Hou Y, Wang N, Guan Y, Tang C et al. Laminar shear stress regulates liver X receptor in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2008;28:527-533.
55. Aguiar M, Masse R, Gibbs BF. Regulation of cytochrome P450 by posttranslational modification. Drug Metab Rev 2005;37:379-404.